PRCSG News

   

 

 

 NEW - FDA approves subcutaneous formulation of ACTEMRA for systemic JIA - September 2018

 

Revised Common Rule: educational videos created by OHRP

 

May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis